Federated Hermes sells 97,549 NERV shares (NASDAQ: NERV) in Form 144 notice
Rhea-AI Filing Summary
Federated Hermes Kaufmann Small Cap Fund reported a sale of 97,549 shares of Common Stock of NERV on 03/10/2026 for $743,274.98. The filing also lists a prior entry showing 534,050 shares of Common Stock described as "Secondary Offering/Open Market" dated 04/15/2015 with Cash as the consideration type.
Positive
- None.
Negative
- None.
Insights
Notice of proposed and reported resale activity by an institutional holder; routine Form 144 disclosure.
Form 144s document intended or completed resales of restricted or control securities. This filing records a reported sale of $743,274.98 for 97,549 shares on 03/10/2026, consistent with an institutional resale.
Cash‑flow treatment is explicit for the reported trade; other line items (e.g., the 04/15/2015 entry for 534,050 shares) are listed as "Secondary Offering/Open Market" with Cash noted. Timing and broader dilution impact are not addressed in the excerpt.
Key Figures
Key Terms
Form 144 regulatory
Secondary Offering/Open Market market
Common Stock financial
FAQ
What did the Form 144 for NERV report?
How much cash was generated by the reported NERV sale?
Does this Form 144 disclose remaining holdings or dilution for NERV?